safety of compounded tirzepatide Eli Lilly just issued a public warning to the compounding industry. In a recent open letter, the pharmaceutical company raised concerns about products being combined with vitamin B12 and marketed in Compounded Semaglutide & Tirzepatide 2025:

Elderly patients : Older adults may be more susceptible to side effects and require careful dose titration Concurrent medications : Patients taking insulin or sulfonylureas may require dose adjustments to reduce hypoglycaemia risk The formal contraindication to tirzepatide in the UK is hypersensitivity to the active substance or to any of the excipients

So thats one opportunity

Patients with pre-existing diabetic retinopathy should have appropriate ophthalmologic follow-up

Roflumilast prevents the metabolic effects of bleomycin-induced fibrosis in a murine model

Retinal complications called diabetic retinopathy worsening have appeared in trial data, primarily in patients with existing diabetes

Semaglutide comes in 3 brands: These all contain semaglutide as the active ingredient